Should intravenous thrombolysis be considered the first option in pregnant women?

Stroke. 2013 Mar;44(3):866-7. doi: 10.1161/STROKEAHA.112.658070. Epub 2013 Feb 7.
No abstract available

MeSH terms

  • Endovascular Procedures
  • Female
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Pregnancy
  • Pregnancy Complications, Cardiovascular / drug therapy*
  • Risk Assessment
  • Stroke / drug therapy*
  • Thrombolytic Therapy*
  • Time Factors
  • Tissue Plasminogen Activator / therapeutic use*

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator